Merck | MRK - SCHULD

Aktienkurs
110.06
Täglich Wechseln
-0.17 -0.15%
Monatlich
-6.81%
Jährlich
29.93%
Q2 Prognose
109.51




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Abbott USD 13.86B 919M 2025-12
ALKERMES USD 71.6M 1.08M 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
J&J USD 47.93B 2.14B 2025-12
Medtronic USD 28.07B 1.03B 2025-12
Merck USD 41.37B 5.97B 2025-09
Novartis USD 35.38B 2.74B 2025-12
Novartis USD 32.02B 615M 2025-09
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.04B 1.7M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
Sanofi EUR 21.76B 530M 2025-09
United Therapeutics USD 200M 100M 2025-03
Zoetis USD 7.27B 482M 2025-09